The list features leaders who have played pivotal roles in AI adoption CHICAGO,March 17,2025-- Relativity,a global legal technology company,today announced its fourth annual list of AI Visionaries. Th
Leading energy distributor achieves core-to-edge modernisation with Oracle\'s finance,HR,and workforce solutions to improve efficiency,support renewables,and enhance customer services
Strengthening Asia\'s Position in the Global Wealth and Investment Landscape MACAO,March 17,2025-- BEYOND Expo,Asia\'s premier platform for technology and innovation,is proud to announce the BEYOND We
TSX/NYSE/PSE:MFCSEHK: 945 Former Chief Actuary to Succeed PhilWitheringtonEffective May 9th TORONTO and HONG KONG,March 18,2025-- Manulife announced that Steve Finch has been appointed President and
Dustin Plantholt appointed Chief Growth Officer Chris Kurtenbach appointed Chief Operating Officer (Jonathan) Del Lockett appointed Chief Strategy Officer
Total audited revenue for 2024 was $19.5 million. The first two months of 2025,our unaudited revenue is about $5.7million,more than 50% growth year over year for the first two months of 2024,and exce
CHONGQING,China,Jan. 27,2025-- During the World Economic Forum\'s 2025 annual meeting held from January 20-24 inDavos-Klosters,Switzerland,nearly 3,000 representatives from 130 countries and regions d
- Addressing Needs of Aging Population and Reducing Workload,Aiming for Expansion in Southeast Asian Markets -
Exclusive expressions blend ex-Bourbon casks across Fino sherry,rum,Manzanilla and brandy casks TAIPEI,Jan. 27,2025-- Kavalan Distillery is proud to unveil The Distiller\'s Reserve Series,an exclusive
HANGZHOU,China,Jan. 27,2025-- On January 25,2025,NetEase Cloud Music,a major player in China\'s music streaming market,announced a crucial development on Friday in its ongoing copyright renewal discus
SINGAPORE,Jan. 27,2025-- Digital travel platform Agoda shares a list of five global events in 2025 that are set to captivate travelers worldwide. These occasions provide opportunities to explore dive
ATLANTA,Jan. 27,2025-- Cambium Oncology is pleased to share that their lead drug candidate,ANT308,recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug i